Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Poly Medicure's share price for the quarter that ended in Mar. 2026 was ₹1191.1. Poly Medicure's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 101 Mil. Therefore, Poly Medicure's market cap for the quarter that ended in Mar. 2026 was ₹120,729 Mil.
Poly Medicure's quarterly market cap
declined
from Sep. 2025 (₹197,457 Mil) to Dec. 2025 (₹179,780 Mil) and
declined
from Dec. 2025 (₹179,780 Mil) to Mar. 2026 (₹120,729 Mil).
Poly Medicure's annual market cap
increased
from Mar. 2024 (₹152,517 Mil) to Mar. 2025 (₹227,502 Mil) but then
declined
from Mar. 2025 (₹227,502 Mil) to Mar. 2026 (₹120,729 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Poly Medicure's Enterprise Value for Today is ₹164,091 Mil.
Poly Medicure (NSE:POLYMED) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Poly Medicure Market Cap Related Terms
Poly Medicure Market Cap Historical Data
* Premium members only.
The historical data trend for Poly Medicure's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:POLYMED vs ISRG, BDX, MDLN: Market Cap Comparison
For the Medical Instruments & Supplies subindustry, Poly Medicure's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Poly Medicure Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Poly Medicure's Market Cap distribution charts can be found below:
* The bar in red indicates where Poly Medicure's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Poly Medicure's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Poly Medicure (NSE:POLYMED) has a Market Cap of ₹168,850 Mil as of Jul. 10, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Poly Medicure and its competitors. According to the industry distribution chart, Poly Medicure ranks #116 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 13.4%.
Is Poly Medicure's Market Cap too high?
Poly Medicure's current Market Cap is ₹168,850 Mil. Based on the distribution chart, Poly Medicure ranks #116 out of 866 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Poly Medicure has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Poly Medicure's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Poly Medicure ranks #116 out of 866 companies for Market Cap. This places Poly Medicure in the top 13% of its industry — outperforming the majority of peers. The industry median Market Cap is 116.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 116.25, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Poly Medicure and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 116.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Poly Medicure's current Market Cap is ₹168,850 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poly Medicure stock overvalued right now?
Based on GuruFocus' analysis, Poly Medicure (NSE:POLYMED) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹2,315.50, compared to a current price of ₹1,668.30 — trading 28% below its estimated fair value. The current Market Cap is ₹168,850 Mil. Poly Medicure's overall GF Score™ is 91/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Poly Medicure (NSE:POLYMED), the current Market Cap is ₹168,850 Mil as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Poly Medicure (NSE:POLYMED) Overvalued in 2026?
Based on GuruFocus' analysis, Poly Medicure stock appears to be undervalued.
The current stock price of ₹1,668.30 is trading 28% below its estimated GF Value™ of ₹2,315.50.
GuruFocus considers Poly Medicure to be Modestly Undervalued.
Key valuation signals for NSE:POLYMED:
Market Cap: ₹168,850 Mil
GF Value™: ₹2,315.50 vs. price of ₹1,668.30 (28% below fair value)
No single metric tells the full story. See the NSE:POLYMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Poly Medicure Ltd engages in the manufacturing and sale of medical devices. It offers disposable medical devices for infusion therapy, blood management, gastroenterology, vascular access, surgery and wound drainage, anesthesia, and urology. Some of its products include Ventilator Circuit Combo Kits, Bain Circuits, Safety Introducer Needles, High-Pressure Vaccum Bottle-Triplet, Catheters, and others. Geographically, it derives a majority of its revenue from exports. The company operates under one segment namely Medical Devices.
91GF Score
Get the complete analysis for NSE:POLYMED
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:POLYMED has been successfully added to your 
